Latest filing published 19 Dec 2022 for NRX Pharmaceuticals, Inc., €31k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Seth Van Voorhees has filed trades across 4 companies (mainly through SEC (Form 4)), most often in American Pacific Corp, Research Frontiers Inc and NRX Pharmaceuticals, Inc. Over a trading history stretching from 17 February 2006 to 16 December 2022, the count stands at 35 filings.
On the market, this insider has only ever bought: 28 purchases, €451k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 7 share grants. In 2022 alone, the filings show 7 purchases and no sales.
A typical purchase (the median) is worth €4,982. Of 6 purchases, 5 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The record was last updated on 19 December 2022 with an open-market purchase (€7,488) in NRX Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations